搜索临床试验以:PCAR-019(抗CD19 CAR-T细胞)
总计1781个结果
-
Chongqing Precision Biotech Co., Ltd招聘中
-
Autolus Limited邀请报名
-
Fudan UniversityGuangzhou Bioresette Biomedical Technology Co., Ltd.; Chaosu Hu,Principal Investigator,Fudan...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou Anjie Biomedical Technology Co., Ltd.完全的
-
Sorrento Therapeutics, Inc.终止
-
The Affiliated Hospital of Xuzhou Medical University招聘中
-
Xuzhou Medical University招聘中
-
Memorial Sloan Kettering Cancer Center招聘中难治性急性淋巴细胞白血病 | 费城-阴性ALL | 费城阳性 ALL | 难治性急性淋巴细胞白血病 (ALL) | 复发性 ALL,成人 | 难治性急性淋巴细胞白血病复发美国
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical University招聘中
-
First Affiliated Hospital of Chengdu Medical College未知
-
Hrain Biotechnology Co., Ltd.First Affiliated Hospital of Wenzhou Medical University; Shanghai Changzheng Hospital招聘中
-
Wuhan Sian Medical Technology Co., LtdWuhan Union Hospital, China; Xiangyang Central Hospital; Jingzhou Central Hospital; People Hospital...招聘中
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital招聘中
-
Seattle Children's HospitalThe Evan Foundation; Ben Towne Center for Childhood Cancer Research主动,不招人
-
Zhejiang UniversityYake Biotechnology Ltd.招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人粘膜相关淋巴组织结外边缘区B细胞淋巴瘤 | 淋巴结边缘区 B 细胞淋巴瘤 | 复发性成人伯基特淋巴瘤 | 复发性成人弥漫性大细胞淋巴瘤 | 复发性成人弥漫性混合细胞淋巴瘤 | 复发性成人弥漫性小裂细胞淋巴瘤 | 复发性成人免疫母细胞大细胞淋巴瘤 | 复发性成人淋巴母细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 脾边缘区淋巴瘤 | 华氏巨球蛋白血症 | 皮肤 B 细胞非霍奇金淋巴瘤 | 眼内淋巴瘤 | 移植后淋巴增生性疾病 | 复发性成人 III 级淋巴瘤样肉芽肿病 | 复发性小淋巴细胞淋巴瘤 | 小肠淋巴瘤 | 睾丸淋巴瘤 | 难治性毛细胞白血病 | 成人 III 级淋巴瘤样肉芽肿病美国
-
Hebei Senlang Biotechnology Inc., Ltd.招聘中
-
Institute of Hematology & Blood Diseases Hospital...Juventas Cell Therapy Ltd.招聘中
-
Shanghai Tongji Hospital, Tongji University School...Cellular Biomedicine Group Ltd.完全的
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical University招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)主动,不招人复发性胶质母细胞瘤 | 复发性恶性胶质瘤 | 难治性恶性胶质瘤 | 复发性 WHO III 级神经胶质瘤 | 复发性 WHO II 级神经胶质瘤 | 难治性胶质母细胞瘤 | 难治性 WHO II 级神经胶质瘤 | 难治性 WHO III 级神经胶质瘤美国
-
Xuzhou Medical University招聘中
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; The Affiliated Nanjing Drum Tower... 和其他合作者招聘中
-
Poseida Therapeutics, Inc.主动,不招人肿瘤 | 组织学类型的肿瘤 | 泌尿生殖系统肿瘤 | 按部位分类的肿瘤 | 生殖器肿瘤,男性 | 前列腺肿瘤 | 腺样囊性癌 | 粘液表皮样癌 | 前列腺癌 | 前列腺肿瘤,去势抵抗 | 转移性去势抵抗性前列腺癌 | 肿瘤,前列腺 | 唾液腺肿瘤 | 唾液腺癌 | 前列腺疾病 | 唾液腺导管癌 | 腺泡细胞瘤美国
-
Poseida Therapeutics, Inc.California Institute for Regenerative Medicine (CIRM)终止
-
The First Affiliated Hospital of Soochow University招聘中
-
Poseida Therapeutics, Inc.招聘中肾细胞癌 | 乳腺癌 | 鼻咽癌 | 胃癌 | 大肠癌 | 胰腺癌 | 卵巢癌 | 非小细胞肺癌 | 头颈部鳞状细胞癌美国
-
Shanghai GeneChem Co., Ltd.Shanghai Cancer Hospital, China未知
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial Hospital招聘中
-
Changhai HospitalNanjing Enricnk Biotech Co., Ltd招聘中
-
The First Affiliated Hospital of Soochow University招聘中